Tag: aTyr Pharma

The biotechnology firm aTyr Pharma faces an unprecedented crisis as its stock value collapses and legal challenges mount. This dramatic ...

After experiencing a severe decline that wiped out more than 80% of its value in September, aTyr Pharma is demonstrating ...

aTyr Pharma's stock experienced a catastrophic decline, plummeting more than 80% after the company announced disappointing results from its pivotal ...

aTyr Pharma's stock continues its downward spiral as disappointing clinical trial results trigger a massive selloff. The biotechnology firm's shares ...

aTyr Pharma's stock faced another challenging session on Friday, declining nearly 6% to close at $0.841 per share. The biotech ...

The stock of biopharmaceutical company aTyr Pharma extended its decline in after-hours trading on Thursday, shedding nearly 6 percent. This ...

The investment community is holding its breath as aTyr Pharma shares enter a period of suspended animation. Market attention is ...

The biotechnology sector is bracing for a pivotal event as aTyr Pharma approaches the release of critical Phase 3 clinical ...